Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics
This interview is disseminated on behalf of Conexeu Sciences Inc.Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration.Learn more: https://www.conexeu.com/Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hUAnd follow us to stay updated: https://www.youtube.com/GlobalOneMedia
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Stocks To Watch
Episode 827: Angkor Resources ($ANK | $ANKOF): Block VIII Oil & Gas Opportunity in Cambodia
Episode 826: Beyond Implants: How Conexeu’s ($CNXU) B.R.E.A.S.T. Could Advance Tissue Regeneration
Episode 825: Renegade Gold ($RAGE | $RENGF) Chairman Discusses Updated Red Lake Project Resource
Episode 824: Paramount Gold Nevada ($PZG) Discusses Updated Grassy Mountain Project Feasibility Study
Get summaries like this every morning.
Free AI-powered recaps of Stocks To Watch and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.